Corisma MCS Systems
CoRISMA MCS Systems: Innovating heart failure treatments with advanced medical devices.
Founded
2018CoRISMA MCS Systems: Innovating heart failure treatments with advanced medical devices.
CoRISMA MCS Systems, founded by cardiac surgeon Pramod Bonde, is a medical device company dedicated to developing innovative treatments for advanced heart failure. Their core mission is to improve the quality of life for patients suffering from this condition through cutting-edge technology. The company's flagship product is a heart failure system designed to provide effective and reliable support for patients with severe heart issues. CoRISMA MCS Systems focuses on the healthcare market, specifically targeting advanced heart failure treatment.
Notable figures affiliated with CoRISMA include CEO Kaushik Mandal, VP of R&D Jim Kelley, and CFO Colin Rolph. The company has achieved significant milestones, such as securing a $550k NIH grant and being selected to present at MedInvest. These accomplishments underscore their impact on the medical device industry and their potential to revolutionize heart failure treatment. CoRISMA's innovative approach and dedicated team position them as a promising player in the healthcare sector.
Companies similar to Corisma MCS Systems include Cormedics, Imricor Medical Systems, Corinnova and MyoCardioCare.
Corisma MCS Systems was founded in 2018.
Corisma MCS Systems' headquarters is located in Hamden, CT, US.
Corisma MCS Systems' most recent funding round was for $27M (USD) in August 2021.
As of Aug 30, 2021, Corisma MCS Systems has disclosed funding of $27M (USD). Undisclosed round amounts are excluded.
Corisma MCS Systems has 30 employees as of Feb 5, 2024.
MyoCardioCare
myocardiocare.com
